| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825180 | Clinical Therapeutics | 2015 | 7 Pages |
Abstract
Novel proteomic markers are better than existing standard tests (alanine transaminase and international normalized ratio) early in the course of paracetamol poisoning. Together with these new biomarkers of hepatotoxicity, a 12-hour acetylcysteine protocol offers clinicians and patients the possibility for better targeting of therapy, fewer adverse effects, a simpler dosing regimen, and shorter hospital stay.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
D. Nicholas BSc, MBBS, MD,